RETINOL MAY PROMOTE FLUOROURACIL-SUPPRESSED HEALING OF EXPERIMENTAL INTESTINAL ANASTOMOSES

Citation
Jwd. Dewaard et al., RETINOL MAY PROMOTE FLUOROURACIL-SUPPRESSED HEALING OF EXPERIMENTAL INTESTINAL ANASTOMOSES, Archives of surgery, 130(9), 1995, pp. 959-965
Citations number
39
Categorie Soggetti
Surgery
Journal title
ISSN journal
00040010
Volume
130
Issue
9
Year of publication
1995
Pages
959 - 965
Database
ISI
SICI code
0004-0010(1995)130:9<959:RMPFHO>2.0.ZU;2-A
Abstract
Objectives: To examine the effects of perioperative administration of fluorouracil on healing variables of intestinal anastomoses and to exp lore ways to promote repair under these conditions. Design: Seven-day, prospective randomized experimental trial. Setting: Animal research l aboratory. Animals: Male young-adult Wistar rats after resection and a nastomosis of both ileum and colon. Interventions: Random assignment t o groups receiving placebo, daily fluorouracil (20 mg/kg per day, intr aperitoneally), daily fluorouracil plus retinol palmitate (5000 IU/kg per day, orally), daily fluorouracil plus interleukin-2 (2X10(6) IU/kg per day, subcutaneously), or daily fluorouracil plus granulocyte macr ophage colony-stimulating factor on the first 4 days after operation ( 20 mu g/kg per day, intraperitoneally). Main Outcome Measures: Anastom otic bursting pres sure, breaking strength, hydroxyproline content, an d ex vivo collagen synthetic capacity. Results: Administration of fluo rouracil decreased anastomotic breaking strength by more than 40% and caused a shift in bursting site from outside to within the suture line . It also lowered anastomotic hydroxyproline content. The capacity for collagen synthesis, which was greatly enhanced in 4-day-old anastomos es from the control group, was significantly (P<.05) and specifically reduced. Concomitant administration of retinol resulted in restoration of strength and hydroxyproline content, particularly in the ileum. In terleukin-2 and granulocyte macrophage colony-stimulating factor did n ot improve fluorouracil-suppressed repair: both wound strength and col lagen content were similar in the fluorouracil, fluorouracil/interleuk in-2, and fluorouracil/granulocyte macrophage colony-stimulating facto r groups. Conclusion: Intraperitoneal administration of fluorouracil, delivered, from the day of operation onward, severely reduces anastomo tic strength at the end of the first postoperative week. This negative effect may be prevented by oral administration of retinol.